Ornithine oxoglutarate
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.047.261 100.023.615, 100.047.261 |
Chemical and physical data | |
Formula | C10H18N2O7 |
Molar mass | 278.261 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Ornithine oxoglutarate (OGO) or ornithine α-ketoglutarate (OKG) is a drug used in liver therapy. It is the salt formed from ornithine and alpha-ketoglutaric acid. It is also used to improve nutritional health in elderly patients.[1][2]
References
- ^ Blonde-Cynober, F; Aussel, C; Cynober, L (2003). "Use of ornithine α-ketoglutarate in clinical nutrition of elderly patients". Nutrition. 19 (1): 73–5. doi:10.1016/S0899-9007(02)00849-3. PMID 12507647.
- ^ Patrice Brocker; Bruno Vellas; Jean-Louis Albarede; Thierry Poynard (July 1994). "A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects". Age and Ageing.